1-6 of 6
Gary I Gorodokin
Close
Sort by
Journal Articles

Reduced Intensity Conditioning Regimen of Autologous Hematopoietic Stem Cell Transplantation±Mitoxantrone Consolidation In Multiple Sclerosis

Andrei A Novik, Aleksey N Kuznetsov, Vladimir Y Melnichenko, Denis A Fedorenko, Andrei V Kartashov, Tatyana I Ionova, Kira A Kurbatova, Gary I Gorodokin
Journal: Blood
Blood (2010) 116 (21): 372.
https://doi.org/10.1182/blood.V116.21.372.372
Published: 2010
Journal Articles

The Utility of the New Instrument for Comprehensive Symptom Profile Assessment In Patients with Multiple Myeloma

Andrei A Novik, Tatyana I Ionova, Svetlana A Kalyadina, Denis A Fedorenko, Nikita E Mochkin, Kira A Kurbatova, Tatyana P Nikitina, Gary I Gorodokin
Journal: Blood
Blood (2010) 116 (21): 4757.
https://doi.org/10.1182/blood.V116.21.4757.4757
Published: 2010
Journal Articles

New Instrument for Comprehensive Symptom Profile Assessment In Patients with Malignant Lymphomas

Andrei A Novik, Tatyana I Ionova, Svetlana A Kalyadina, Denis A Fedorenko, Nikita E Mochkin, Kira A Kurbatova, Tatyana P Nikitina, Gary I Gorodokin
Journal: Blood
Blood (2010) 116 (21): 2561.
https://doi.org/10.1182/blood.V116.21.2561.2561
Published: 2010
Journal Articles

Multicenter Experience of High Dose Chemotherapy (HDCT)+Autologous Stem Cell Transplantation (ASCT) in Multiple Sclerosis (MS) Patients.

Yury L. Shevchenko, Andrei A. Novik, Alexey N. Kuznetcov, Boris V. Afanasiev, Igor A. Lisukov, Oleg A. Rykavicin, Alexandr A. Myasnikov, Tatiana I. Ionova, PhD, Sergey V. Shamanski, MD,PhD, Andrey D. Kulagin, MD,PhD, Olga A. Malysheva, MD, Nikolay I. Baziy, MD,PhD, Vladimir Y. Melnichenko, MD,PhD, Denis A. Fedorenko, MD,PhD, Inna V. Vereschagina, MD, Andrey E. Zdorov, MD, Anton V. Kishtovich, PhD, Roman A. Ivanov, PhD, Yury N. Fedotov, MD,PhD, Gary I. Gorodokin, MD
Journal: Blood
Blood (2006) 108 (11): 3072.
https://doi.org/10.1182/blood.V108.11.3072.3072
Published: 2006
Journal Articles

Treatment Outcomes in Multiple Sclerosis (MS) Patients after Early, Conventional and Salvage High Dose Chemotherapy (HDCT)+Autologous Stem Cell Transplantation (ASCT).

Yury L. Shevchenko, Andrei A. Novik, Boris V. Afanasiev, Igor A. Lisukov, Tatiana I. Ionova, PhD, Andrei D. Kulagin, MD, Olga A. Malysheva, MD, Gennady N. Bisaga, MD, PhD, Vladimir J. Melnichenko, MD, PhD, Sergei V. Voloshin, MD, PhD, Denis A. Fedorenko, MD, PhD, Inna V. Vereschagina, MD, Anton V. Kishtovich, PhD, Yury N. Fedotov, MD, PhD, Gary I. Gorodokin, MD
Journal: Blood
Blood (2005) 106 (11): 5467.
https://doi.org/10.1182/blood.V106.11.5467.5467
Published: 2005
Journal Articles

Quality of Life (QoL) Impairment and International Prognostic Index (IPI) in New Aggressive Non-Hodgkin’s Lymphoma (ANHL) Patients.

Andrei A. Novik, Tatiana I. Ionova, PhD, Anton V. Kishtovich, PhD, Alexander A. Myasnikov, Tatiana V. Chagorova, MD, PhD, Mikhail V. Kopp, Nina E. Osipova, MD, Julia K. Lebedeva, MD, Natalia N. Malakchova, MD, Anastasia V. Pankova, Denis A. Fedorenko, MD, PhD, Gary I. Gorodokin, MD
Journal: Blood
Blood (2005) 106 (11): 4651.
https://doi.org/10.1182/blood.V106.11.4651.4651
Published: 2005